BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2411609)

  • 1. Some further features for differential diagnosis between squamous cell carcinomas and basal cell epitheliomas.
    Tosca A; Varelzidis A; Bassioukas K; Hatzis J; Nicolis G; Stratigos J
    Dermatologica; 1985; 171(1):21-6. PubMed ID: 2411609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
    Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
    J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light microscopic autoradiographical analysis of [125I]epidermal growth factor binding in basal cell epithelioma and squamous cell carcinoma of the skin.
    Ikeuchi T; Urano Y; Fukuhara K; Nakanishi H; Arase S
    J Dermatol; 1993 Apr; 20(4):219-25. PubMed ID: 8315111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin.
    Tellechea O; Reis JP; Domingues JC; Baptista AP
    Am J Dermatopathol; 1993 Oct; 15(5):452-5. PubMed ID: 8238781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
    Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
    J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a monoclonal antibody (VM-2) plus the immunogold-silver technique to stain basal cell carcinoma cells.
    Morhenn VB; Roth S; Roth R
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):765-9. PubMed ID: 2445798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.
    Lavrijsen AP; Tieben LM; Ponec M; van der Schroeff JG; van Muijen GN
    Arch Dermatol Res; 1989; 281(2):83-8. PubMed ID: 2476080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of epidermal growth factor receptors in basal and squamous cell carcinoma.
    Springer EA; Robinson JK
    J Dermatol Surg Oncol; 1991 Jan; 17(1):20-4. PubMed ID: 1991877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytologic aspects of the differential diagnosis of basalioma].
    von Gizycki-Nienhaus B; Kaudewitz P
    Hautarzt; 1992 Oct; 43(10):629-33. PubMed ID: 1428871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of keratin proteins in basal and squamous cell carcinomas of the skin. An immunohistochemical study.
    Thomas P; Said JW; Nash G; Banks-Schlegel S
    Lab Invest; 1984 Jan; 50(1):36-41. PubMed ID: 6198559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
    Yu L; Galan A; McNiff JM
    J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of cytology in basal cell and squamous cell carcinomas.
    Oram Y; Turhan O; Aydin NE
    Int J Dermatol; 1997 Feb; 36(2):156-7. PubMed ID: 9109022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytodiagnosis of benign, precancerous and malignant skin changes].
    Nauth HF; Gizycki-Nienhaus B
    Z Hautkr; 1988 May; 63(5):430-8. PubMed ID: 3407259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
    Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
    Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bowenoid basocellular carcinomas (basaliomas with cellular monstrosities].
    GarcĂ­a e Silva L; Pereira F
    Med Cutan Ibero Lat Am; 1986; 14(6):387-90. PubMed ID: 3550312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous squamous cell carcinomas of the lower extremity: a distinct subset of squamous cell carcinomas.
    Kim C; Ko CJ; Leffell DJ
    J Am Acad Dermatol; 2014 Jan; 70(1):70-4. PubMed ID: 24210370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal.
    Webb DV; Mentrikoski MJ; Verduin L; Brill LB; Wick MR
    Ann Diagn Pathol; 2015 Apr; 19(2):70-5. PubMed ID: 25702956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dermal cellular infiltrate and cell-mediated immunity in skin carcinomas.
    Avgerinou G; Nicolis G; Vareltzidis A; Stratigos J
    Dermatologica; 1985; 171(4):238-42. PubMed ID: 4076497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
    Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
    Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.